Cavuslu S, Mant C, Starkey W G, Bible J M, Biswas C, Kell B, Rice P, Best J M, Cason J
Richard Dimbleby Laboratory of Cancer Virology, Department of Virology, Rayne Institute, United Medical School of Guy's Hospital, London, England.
J Med Virol. 1996 Aug;49(4):319-24. doi: 10.1002/(SICI)1096-9071(199608)49:4<319::AID-JMV10>3.0.CO;2-5.
Human papillomavirus type 16 (HPV-16) DNA is detected commonly in cervical carcinomas; in this study, we have determined the analytical sensitivities of Hybrid Capture, HPV-consensus PCR, and three HPV-16-specific polymerase chain reactions (PCRs) for the detection of HPV-16 DNA. Samples investigated included a cervical cancer cell line, cervical scrapes from 20 patients attending colposcopy clinics, and buccal swabs from eight immunosuppressed children. HPV-16 E7 and E5-nested PCRs [Cavuslu et al. (1996): Journal of Virological Methods, in press] produced positive signals from samples containing fewer than ten HPV-16 genomes per reaction. HPV-consensus PCR [Manos et al. (1989): Cancer Cells 7:209-214] and HPV-16 PCR using primers of van den Brule et al. [(1990): Journal of Clinical Microbiology 25:2739-2743] were of intermediate sensitivity (i.e., produced positive signals from samples containing 250 and 2,500 HPV-16 genoms/reaction, respectively) and Hybrid Capture could detect just 50,000 HPV-16 genomes/reaction. Highest rates of positivity for cervical samples were detected with HPV-16 E7 or E5-nested PCRs [50% (10 of 20 samples) and 60% (12 of 20 samples) positive, respectively], intermediate rates with HPV-consensus PCR and PCRs using the primers of van den Brule et al. [both 35% (7 of 20 samples)], and lowest rates of positivity [25% (5 of 20 samples)] with Hybrid Capture. None of eight buccal swab samples from immunosuppressed children were positive by Hybrid Capture, yet three (37.5%) were positive by HPV-16 E5-nested PCR. These data indicate that HPV-16 type-specific PCRs should be used for the investigation of specimens that may contain low amounts of HPV-16 DNA.
人乳头瘤病毒16型(HPV - 16)DNA在宫颈癌中普遍被检测到;在本研究中,我们测定了杂交捕获法、HPV通用型聚合酶链反应(PCR)以及三种HPV - 16特异性聚合酶链反应(PCR)检测HPV - 16 DNA的分析灵敏度。所研究的样本包括一种宫颈癌细胞系、来自20名接受阴道镜检查门诊患者的宫颈刮片以及来自8名免疫抑制儿童的口腔拭子。HPV - 16 E7和E5巢式PCR [Cavuslu等人(1996年):《病毒学方法杂志》,即将发表] 能从每个反应中含有少于10个HPV - 16基因组的样本中产生阳性信号。HPV通用型PCR [Manos等人(1989年):《癌细胞》7:209 - 214] 以及使用van den Brule等人 [(1990年):《临床微生物学杂志》25:2739 - 2743] 的引物进行的HPV - 16 PCR灵敏度中等(即分别能从每个反应中含有250和2500个HPV - 16基因组的样本中产生阳性信号),而杂交捕获法只能检测到每个反应50,000个HPV - 16基因组。宫颈样本中HPV - 16 E7或E5巢式PCR检测到的阳性率最高 [分别为50%(20个样本中的10个)和60%(20个样本中的12个)呈阳性],HPV通用型PCR以及使用van den Brule等人的引物进行的PCR阳性率中等 [均为35%(20个样本中的7个)],杂交捕获法的阳性率最低 [25%(20个样本中的5个)]。免疫抑制儿童的8份口腔拭子样本中,杂交捕获法均未检测到阳性,但HPV - 16 E5巢式PCR检测到3份(37.5%)呈阳性。这些数据表明,HPV - 16型特异性PCR应用于检测可能含有少量HPV - 16 DNA的标本。